Furthermore, experimental evidence indicates that administration of a monoclonal antibody specifically targeting Itgam, an adhesion molecule, can attenuate neutrophil-mediated myocardial ischemia–reperfusion injury (MIRI) in canine models (Simpson et al., 2025). The gene discussed is ITGAM; the disease is myocardial ischemia.